Skip to content

Femoral Closure Versus Radial Compression Devices Related to Percutaneous Coronary Interventions Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02455661
Acronym
FERARI
Enrollment
600
Registered
2015-05-28
Start date
2014-02-28
Completion date
2019-10-31
Last updated
2019-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Access Site Bleeding, Adverse Cardiac Events, Arterial Closure Device, Percutaneous Coronary Intervention (PCI)

Brief summary

FERARI is a single centre observational study comparing patients undergoing PCI either using radial compression devices or femoral closure devices at the corresponding access site. First primary outcomes consist of the occurrence of vascular complications at the arterial access site including major bleedings as defined by common classification systems Second primary outcomes consist of the occurrence of adverse cardiac events including all-cause mortality, target lesion and vessel revascularization (TLR and TVR) during 30 days and 12 months of follow-up.

Interventions

DEVICETR Band (TM)
DEVICEAngioSeal
DEVICEStarClose

Sponsors

Universitätsmedizin Mannheim
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Radial closure by TR-Band.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent about the study * Elective PCI with following indications: Stable coronary artery disease, proven myocardial ischemia; cardiac arrhythmia; syncope; Unstable AP defined as NSTEMI but without cardiac troponin elevation; NSTEMI; STEMI * patient eligible for coronary angiography and both radial and femoral PCI * requirement of using a vascular closure device (without contraindications)

Exclusion criteria

* inability to understand and sign the informed consent term * pregnancy * less 18 years of age * single diagnostic coronary angiography * active or high bleeding risk (thrombocytopenia \<50,000/µl) * femoral approach and PCI without using a vascular closure device * other conditions hampering involvement in the study

Design outcomes

Primary

MeasureTime frameDescription
Vascular complications at the arterial access site30 daysOccurrence of vascular complications at the arterial access site including major bleedings as defined by common classification systems
Adverse cardiac events30 daysOccurrence of adverse cardiac events including all-cause mortality, target lesion and vessel revascularization (TLR and TVR).

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026